Vectura Acquires SkyePharma for US$628 M to Lead in Inhalation Devices
By Heather Cartwright & Rohit Khera
Pharma Deals Review: Vol 2016 Issue 4 (Table of Contents)
Published: 19 Apr-2016
DOI: 10.3833/pdr.v2016.i4.2154 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a welcome act of consolidation in the UK biotech industry, Vectura has agreed to acquire its peer SkyePharma in an all-stock deal that values the drug delivery company at £441...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS